The opinion
UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION
IN RE: XARELTO (RIVAROXABAN)
PRODUCTS LIABILITY LITIGATION MDL No. 2592
(SEE ATTACHED SCHEDULE)
CONDITIONAL TRANSFER ORDER (CTO —196)
On December 12, 2014, the Panel transferred 20 civil action(s) to the United States District Court
for the Eastern District of Louisiana for coordinated or consolidated pretrial proceedings pursuant to
28 U.S.C. § 1407. See 65 F.Supp.3d 1402 (J.P.M.L. 2014). Since that time, 708 additional action(s)
have been transferred to the Eastern District of Louisiana. With the consent of that court, all such
actions have been assigned to the Honorable Eldon E. Fallon.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the Eastern District of Louisiana and assigned to
Judge Fallon.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
Eastern District of Louisiana for the reasons stated in the order of December 12, 2014, and, with the
consent of that court, assigned to the Honorable Eldon E. Fallon.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the Eastern District of Louisiana. The transmittal of this order to said Clerk shall
be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7-day period, the stay will be continued until further order of the Panel.
Inasmuch as no objection is FOR THE PANEL:
Seis ited. time, the VL. Z AC
Dec 18, 2019
CLERK'S OFFICE John W. Nichols
□□□ thon Clerk of the Panel] CbERK’S OFFICE
A-TRUE COPY,
Dec 19 2019
ZI
fyit J □□ 4
aputy U.S. District Court
| astel rofeesr en
IN RE: XARELTO (RIVAROXABAN)
PRODUCTS LIABILITY LITIGATION MDL No. 2592
SCHEDULE CTO−196 − TAG−ALONG ACTIONS
DIST DIV. C.A.NO. CASE CAPTION
CALIFORNIA NORTHERN
Brown et al v. Janssen Research & Development LLC et
19-14669 CAN 3 19−07619
al